Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Alba Therapeutics licenses IP from U. of Maryland, Baltimore

Executive Summary

Alba Therapeutics (hopes to develop drugs and drug delivery adjuvants) has acquired exclusive rights from the University of Maryland, Baltimore to about 100 patents pertaining to the use of the zonulin endogenous signaling pathway for all applications, excluding clinical diagnostics.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register